CAR‑T is no universal miracle drug. It has well‑defined eligibility criteria, standardised workflows and controllable risks. Nor is it always a patient’s final therapeutic option; for many high‑risk haematology patients, it may represent the first step toward cure. Anxious patients are advised not to draw premature conclusions or give up hope. Bring your complete medical records for comprehensive assessment by an experienced CAR‑T team to identify the most suitable treatment